Apelin reduces myocardial reperfusion injury independently of PI3K/Akt and P70S6 kinase

Regulatory Peptides

Volumn 146, Issue 1-3, 2008, Pages 271-277

  Kleinz, Matthias J ^a   Baxter, Gary F ^b  

^a ROYAL VETERINARY COLLEGE   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

APJ; Autacoid; Cardioprotection; G protein coupled receptor; Langendorff; RISK pathway

Indexed keywords

APELIN; APELIN RECEPTOR; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; RAPAMYCIN; S6 KINASE; TETRAZOLIUM; WORTMANNIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISOLATED HEART; LEFT CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; REPERFUSION INJURY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CARRIER PROTEINS; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; RNA, MESSENGER;

RATTUS;

EID: 38349174739     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2007.10.002     Document Type: Article

References (44)

1. O'Dowd B.F., Heiber M., Chan A., Heng H.H., Tsui L.C., Kennedy J.L., Shi X., Petronis A., George S.R., and Nguyen T. A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11. Gene 136 1-2 (1993) 355-360
2. Lee D.K., Cheng R., Nguyen T., Fan T., Kariyawasam A.P., Liu Y., Osmond D.H., George S.R., and O'Dowd B.F. Characterization of apelin, the ligand for the APJ receptor. J Neurochem 74 1 (2000) 34-41
3. Kleinz M.J., and Davenport A.P. Emerging roles of apelin in biology and medicine. Pharmacol Ther 107 2 (2005) 198-211
4. Charles C.J. Putative role for apelin in pressure/volume homeostasis and cardiovascular disease. Cardiovasc Hematol Agents Med Chem 5 1 (2007) 1-10
5. Lee D.K., George S.R., and O'Dowd B.F. Unravelling the roles of the apelin system: prospective therapeutic applications in heart failure and obesity. Trends Pharmacol Sci 27 4 (2006) 190-194
6. Masri B., Knibiehler B., and Audigier Y. Apelin signalling: a promising pathway from cloning to pharmacology. Cell Signal 17 4 (2005) 415-426
7. Cox C.M., D'Agostino S.L., Miller M.K., Heimark R.L., and Krieg P.A. Apelin, the ligand for the endothelial G-protein-coupled receptor, APJ, is a potent angiogenic factor required for normal vascular development of the frog embryo. Dev Biol 296 1 (2006) 177-189
8. Kalin R.E., Kretz M.P., Meyer A.M., Kispert A., Heppner F.L., and Brandli A.W. Paracrine and autocrine mechanisms of apelin signaling govern embryonic and tumor angiogenesis. Dev Biol 305 2 (2007) 599-614
9. Scott I.C., Masri B., D'Amico L.A., Jin S.W., Jungblut B., Wehman A.M., Baier H., Audigier Y., and Stainier D.Y. The g protein-coupled receptor agtrl1b regulates early development of myocardial progenitors. Dev Cell 12 3 (2007) 403-413
10. Zeng X.X., Wilm T.P., Sepich D.S., and Solnica-Krezel L. Apelin and its receptor control heart field formation during zebrafish gastrulation. Dev Cell 12 3 (2007) 391-402
11. Ashley E.A., Powers J., Chen M., Kundu R., Finsterbach T., Caffarelli A., Deng A., Eichhorn J., Mahajan R., Agrawal R., Greve J., Robbins R., Patterson A.J., Bernstein D., and Quertermous T. The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. Cardiovasc Res 65 1 (2005) 73-82
12. Berry M.F., Pirolli T.J., Jayasankar V., Burdick J., Morine K.J., Gardner T.J., and Woo Y.J. Apelin has in vivo inotropic effects on normal and failing hearts. Circulation 110 11 Suppl 1 (2004) II187-II193
13. Farkasfalvi K., Stagg M.A., Coppen S.R., Siedlecka U., Lee J., Soppa G.K., Marczin N., Szokodi I., Yacoub M.H., and Terracciano C.M. Direct effects of apelin on cardiomyocyte contractility and electrophysiology. Biochem Biophys Res Commun 357 4 (2007) 889-895
14. Szokodi I., Tavi P., Foldes G., Voutilainen-Myllyla S., Ilves M., Tokola H., Pikkarainen S., Piuhola J., Rysa J., Toth M., and Ruskoaho H. Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circ Res 91 5 (2002) 434-440
15. Charles C.J., Rademaker M.T., and Richards A.M. Apelin-13 induces a biphasic haemodynamic response and hormonal activation in normal conscious sheep. J Endocrinol 189 3 (2006) 701-710
16. Cheng X., Cheng X.S., and Pang C.C. Venous dilator effect of apelin, an endogenous peptide ligand for the orphan APJ receptor, in conscious rats. Eur J Pharmacol 470 3 (2003) 171-175
17. Hashimoto T., Kihara M., Ishida J., Imai N., Yoshida S., Toya Y., Fukamizu A., Kitamura H., and Umemura S. Apelin stimulates myosin light chain phosphorylation in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 26 6 (2006) 1267-1272
18. Ishida J., Hashimoto T., Hashimoto Y., Nishiwaki S., Iguchi T., Harada S., Sugaya T., Matsuzaki H., Yamamoto R., Shiota N., Okunishi H., Kihara M., Umemura S., Sugiyama F., Yagami K., Kasuya Y., Mochizuki N., and Fukamizu A. Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo. J Biol Chem 279 25 (2004) 26274-26279
19. Katugampola S.D., Maguire J.J., Matthewson S.R., and Davenport A.P. [(125)I]-(Pyr(1))Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man. Br J Pharmacol 132 6 (2001) 1255-1260
20. Kleinz M.J., Maguire J.J., and Davenport A.P. Pyr1-apelin-13 is a potent endothelium dependent vasodilator in human artery opposing vasoconstriction via APJ receptors. pA2 online abstracts of the British Pharmacologiacl Society (2005)
21. Lee D.K., Saldivia V.R., Nguyen T., Cheng R., George S.R., and O'Dowd B.F. Modification of the terminal residue of Apelin-13 antagonises its hypotensive action. Endocrinology 146 1 (2005) 231-236
22. Tatemoto K., Takayama K., Zou M.X., Kumaki I., Zhang W., Kumano K., and Fujimiya M. The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regul Pept 99 2-3 (2001) 87-92
23. Zhang J., Ren C.X., Qi Y.F., Lou L.X., Chen L., Zhang L.K., Wang X., and Tang C. Exercise training promotes expression of apelin and APJ of cardiovascular tissues in spontaneously hypertensive rats. Life Sci 79 12 (2006) 1153-1159
24. Iwanaga Y., Kihara Y., Takenaka H., and Kita T. Down-regulation of cardiac apelin system in hypertrophied and failing hearts: possible role of angiotensin II-angiotensin type 1 receptor system. J Mol Cell Cardiol 41 5 (2006) 798-806
25. Dai T., Ramirez-Correa G., and Gao W.D. Apelin increases contractility in failing cardiac muscle. Eur J Pharmacol 553 1-3 (2006) 222-228
26. Foldes G., Horkay F., Szokodi I., Vuolteenaho O., Ilves M., Lindstedt K.A., Mayranpaa M., Sarman B., Seres L., Skoumal R., Lako-Futo Z., deChatel R., Ruskoaho H., and Toth M. Circulating and cardiac levels of apelin, the novel ligand of the orphan receptor APJ, in patients with heart failure. Biochem Biophys Res Commun 308 3 (2003) 480-485
27. Atluri P., Morine K.J., Liao G.P., Panlilio C.M., Berry M.F., Hsu V.M., Hiesinger W., Cohen J.E., and Joseph Woo Y. Ischemic heart failure enhances endogenous myocardial apelin and APJ receptor expression. Cell Mol Biol Lett 12 1 (2007) 127-138
28. Ronkainen V.P., Ronkainen J.J., Hanninen S.L., Leskinen H., Ruas J.L., Pereira T., Poellinger L., Vuolteenaho O., and Tavi P. Hypoxia inducible factor regulates the cardiac expression and secretion of apelin. FASEB J 21 8 (2007) 1821-1830
29. Jia Y.X., Pan C.S., Zhang J., Geng B., Zhao J., Gerns H., Yang J., Chang J.K., Tang C.S., and Qi Y.F. Apelin protects myocardial injury induced by isoproterenol in rats. Regul Pept 133 1-3 (2006) 147-154
30. Hausenloy D.J., and Yellon D.M. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the reperfusion injury salvage kinase (RISK)-pathway. Cardiovasc Res 61 3 (2004) 448-460
31. 2S) protects against regional myocardial ischemia-reperfusion injury-evidence for a role of K ATP channels. Basic Res Cardiol 101 1 (2006) 53-60
32. Mittmann C., Eschenhagen T., and Scholz H. Cellular and molecular aspects of contractile dysfunction in heart failure. Cardiovasc Res 39 2 (1998) 267-275
33. Erhardt L.R. A review of the current evidence for the use of angiotensin-receptor blockers in chronic heart failure. Int J Clin Pract 59 5 (2005) 571-578
34. Piper H.M., Meuter K., and Schafer C. Cellular mechanisms of ischemia-reperfusion injury. Ann Thorac Surg 75 2 (2003) S644-S648
35. Burley DS, Hamid SA, Baxter GF. Cardioprotective actions of peptide hormones in myocardial ischemia. Heart Fail Rev 2007; Electronic publication.
36. Tatemoto K., Hosoya M., Habata Y., Fujii R., Kakegawa T., Zou M.X., Kawamata Y., Fukusumi S., Hinuma S., Kitada C., Kurokawa T., Onda H., and Fujino M. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun 251 2 (1998) 471-476
37. Kawamata Y., Habata Y., Fukusumi S., Hosoya M., Fujii R., Hinuma S., Nishizawa N., Kitada C., Onda H., Nishimura O., and Fujino M. Molecular properties of apelin: tissue distribution and receptor binding. Biochim Biophys Acta 1538 2-3 (2001) 162-171
38. Masri B., Morin N., Pedebernade L., Knibiehler B., and Audigier Y. The apelin receptor is coupled to Gi1 or Gi2 protein and is differentially desensitized by apelin fragments. J Biol Chem 281 27 (2006) 18317-18326
39. Petersen S.P., Scarborough V., Rayner P., and M. European cardiovascular disease statistics. BHF (2005). http://www.heartstats.org/datapage.asp online; http://www.heartstats.org/datapage.asp?id=1570
40. Hausenloy D.J., Maddock H.L., Baxter G.F., and Yellon D.M. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?. Cardiovasc Res 55 3 (2002) 534-543
41. Masri B., Morin N., Cornu M., Knibiehler B., and Audigier Y. Apelin (65-77) activates p70 S6 kinase and is mitogenic for umbilical endothelial cells. FASEB J 18 15 (2004) 1909-1911
42. Simpkin JC, Yellon DM, Davidson SM, Lim SY, Wynne AM, Smith CC. Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemiareperfusion injury. Basic Res Cardiol 2007; Electronic publication.
43. + channels via the EP3 receptor. Am J Physiol Heart Circ Physiol 288 5 (2005) H2093-H2101
44. Hamid S.A., Bower H.S., and Baxter G.F. Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium. Am J Physiol Heart Circ Physiol 292 6 (Jun 2007) H2598-H2606